[Asia Economy Reporter Han Seung-gon] On the 2nd (local time), the White House announced that U.S. President Donald Trump, who tested positive for the novel coronavirus infection (COVID-19), was administered the antiviral drug Remdesivir. Remdesivir is an antiviral drug developed by the pharmaceutical company Gilead Sciences as a treatment for Ebola.



Additionally, Bill Stepien, the Trump campaign chief, was also reported to have tested positive for COVID-19.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing